Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Debt (2018 - 2025)

Dna X filings provide 6 years of Non-Current Debt readings, the most recent being $250000.0 for Q3 2025.

  • On a quarterly basis, Non-Current Debt changed N/A to $250000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $250000.0, a N/A change, with the full-year FY2021 number at $66000.0, down 64.32% from a year prior.
  • Non-Current Debt hit $250000.0 in Q3 2025 for Dna X, down from $566000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $566000.0 in Q1 2025 to a low of $30000.0 in Q1 2022.
  • Median Non-Current Debt over the past 3 years was $92500.0 (2021), compared with a mean of $160250.0.
  • The widest YoY moves for Non-Current Debt: up 50.0% in 2022, down 79.73% in 2022.
  • Dna X's Non-Current Debt stood at $66000.0 in 2021, then tumbled by 43.94% to $37000.0 in 2022, then skyrocketed by 575.68% to $250000.0 in 2025.
  • The last three reported values for Non-Current Debt were $250000.0 (Q3 2025), $566000.0 (Q1 2025), and $37000.0 (Q3 2022) per Business Quant data.